See more : Amplitude Healthcare Acquisition Corporation (AMHCW) Income Statement Analysis – Financial Results
Complete financial analysis of Aleafia Health Inc. (AH.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aleafia Health Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Canature Health Technology Co., Ltd. (300272.SZ) Income Statement Analysis – Financial Results
- DT Cloud Star Acquisition Corporation (DTSQU) Income Statement Analysis – Financial Results
- Britvic plc (BVIC.L) Income Statement Analysis – Financial Results
- J-Stream Inc. (4308.T) Income Statement Analysis – Financial Results
- Sable Offshore Corp. (SOC) Income Statement Analysis – Financial Results
Aleafia Health Inc. (AH.TO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.aleafiahealth.com
About Aleafia Health Inc.
Aleafia Health Inc. operates as a cannabis health and wellness products and services company in Canada and internationally. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates. In addition, the company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners; and operates education centers. It offers its products under the Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips, and Emblem brands. The company is headquartered in Concord, Canada.
| Metric | 2022 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.85M | 44.54M | 16.35M | 3.33M | 15.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 36.85M | 50.15M | -4.43M | 541.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 6.00M | -5.61M | 20.78M | 2.79M | 15.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 14.00% | -12.59% | 127.10% | 83.73% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 17.70M | 31.94M | 38.85M | 20.01M | 9.53M | 65.10K | 130.05K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 0.00 | 0.00 |
| Selling & Marketing | 2.46M | 0.00 | 0.00 | 933.43K | 114.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.17M | 31.94M | 38.85M | 20.94M | 9.65M | 65.10K | 130.05K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 160.45K | 87.16K |
| Other Expenses | 3.37M | 8.06M | 5.91M | 1.66M | 60.46K | 52.98K | 16.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 23.54M | 40.00M | 44.77M | 22.60M | 9.71M | 65.10K | 146.68K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 160.45K | 87.16K |
| Cost & Expenses | 60.39M | 90.15M | 40.33M | 23.14M | 9.71M | 65.10K | 146.68K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 160.45K | 87.16K |
| Interest Income | 0.00 | 0.00 | 417.00K | 169.84K | 0.00 | 0.00 | 0.00 | 61.00 | 169.00 | 4.14K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.36M | 403.53M | 6.38M | 0.00 | 0.00 | 2.42K | 1.40K | 0.00 | 1.71K | 0.00 | 14.70K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 6.57M | 10.16M | 6.63M | 1.56M | 60.46K | 0.00 | 0.00 | 61.00 | 169.00 | 4.14K | -70.00K | 0.00 | 951.64K | 0.00 |
| EBITDA | -10.97M | 163.92M | -17.35M | -18.25M | -9.63M | -12.12K | -146.68K | -178.22K | -515.44K | -2.57M | -554.84K | -86.27K | 791.19K | -87.16K |
| EBITDA Ratio | -25.61% | 368.01% | -106.12% | -548.10% | -61,089.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -17.54M | 153.75M | -23.98M | -19.81M | -9.69M | -12.12K | -146.68K | -178.28K | -515.61K | -2.57M | -484.84K | -86.27K | -160.45K | -87.16K |
| Operating Income Ratio | -40.93% | 345.19% | -146.68% | -594.92% | -61,473.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -17.07M | -403.53M | -12.67M | 269.84K | 0.00 | 2.13K | -1.40K | -2.97M | 7.54K | 8.31K | 57.00K | 0.00 | -951.64K | 0.00 |
| Income Before Tax | -34.61M | -249.78M | -36.65M | -19.54M | -9.69M | -9.98K | -148.08K | -3.14M | -509.62K | -2.56M | -512.55K | -86.27K | -1.11M | -87.16K |
| Income Before Tax Ratio | -80.77% | -560.77% | -224.13% | -586.81% | -61,473.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 7.71M | -2.54M | 2.96M | -1.01M | 0.00 | -4.55K | 0.00 | 2.97M | -7.71K | -12.45K | -10.31K | 0.00 | 951.64K | 0.00 |
| Net Income | -42.32M | -247.24M | -39.61M | -18.53M | -9.69M | -5.44K | -148.08K | -3.14M | -509.62K | -2.56M | -502.24K | -86.27K | -1.11M | -87.16K |
| Net Income Ratio | -98.77% | -555.07% | -242.23% | -556.55% | -61,473.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.11 | -0.85 | -0.18 | -0.16 | -0.24 | -0.01 | -0.15 | -3.15 | -0.57 | -3.50 | -1.17 | -0.20 | -14.51 | -0.20 |
| EPS Diluted | -0.11 | -0.85 | -0.18 | -0.16 | -0.24 | -0.01 | -0.15 | -3.15 | -0.57 | -3.50 | -1.17 | -0.20 | -14.51 | -0.20 |
| Weighted Avg Shares Out | 386.36M | 291.59M | 215.62M | 117.16M | 39.98M | 998.95K | 998.95K | 998.95K | 898.88K | 730.95K | 430.20K | 430.20K | 76.63K | 430.20K |
| Weighted Avg Shares Out (Dil) | 386.36M | 291.59M | 215.62M | 117.16M | 39.98M | 998.95K | 998.95K | 998.95K | 898.88K | 730.95K | 430.20K | 430.20K | 76.63K | 430.20K |
Source: https://incomestatements.info
Category: Stock Reports